InMed Pharmaceuticals Inc. (INM): Total Assets
$3.03M
As of 2026-06-30
-40.1%
3-year compound annual growth
-20.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $3.03M | -80.6% | 2026-09-09, Balance as of period end |
| 2025-06-30 | $15.58M | +31.8% | 2026-09-09, Balance as of period end |
| 2024-06-30 | $11.82M | -16.2% | 2025-09-23, Balance as of period end |
| 2023-06-30 | $14.11M | +10.3% | 2024-09-30, Balance as of period end |
| 2022-06-30 | $12.79M | +30.7% | 2023-09-29, Balance as of period end |
| 2021-06-30 | $9.78M | +25.4% | 2022-09-23, Balance as of period end |
| 2020-06-30 | $7.80M | n/a | 2021-09-24, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $3.03M | -80.6% |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | $3.07M | +90.2% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.97M | +7.7% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $2.93M | +9.7% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Palatin Technologies Inc (PTN) | 2025-06-30 | $3.27M | -69.6% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.81M | -49.4% |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | $2.80M | -40.4% |
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $3.65M | n/m |
Compare INM, HEPA, TCRT, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗